The HIV-1 reservoir landscape in persistent elite controllers and transient elite controllers
- PMID: 38376918
- PMCID: PMC11014653
- DOI: 10.1172/JCI174215
The HIV-1 reservoir landscape in persistent elite controllers and transient elite controllers
Abstract
BACKGROUNDPersistent controllers (PCs) maintain antiretroviral-free HIV-1 control indefinitely over time, while transient controllers (TCs) eventually lose virological control. It is essential to characterize the quality of the HIV reservoir in terms of these phenotypes in order to identify the factors that lead to HIV progression and to open new avenues toward an HIV cure.METHODSThe characterization of HIV-1 reservoir from peripheral blood mononuclear cells was performed using next-generation sequencing techniques, such as full-length individual and matched integration site proviral sequencing (FLIP-Seq; MIP-Seq).RESULTSPCs and TCs, before losing virological control, presented significantly lower total, intact, and defective proviruses compared with those of participants on antiretroviral therapy (ART). No differences were found in total and defective proviruses between PCs and TCs. However, intact provirus levels were lower in PCs compared with TCs; indeed the intact/defective HIV-DNA ratio was significantly higher in TCs. Clonally expanded intact proviruses were found only in PCs and located in centromeric satellite DNA or zinc-finger genes, both associated with heterochromatin features. In contrast, sampled intact proviruses were located in permissive genic euchromatic positions in TCs.CONCLUSIONSThese results suggest the need for, and can give guidance to, the design of future research to identify a distinct proviral landscape that may be associated with the persistent control of HIV-1 without ART.FUNDINGInstituto de Salud Carlos III (FI17/00186, FI19/00083, MV20/00057, PI18/01532, PI19/01127 and PI22/01796), Gilead Fellowships (GLD22/00147). NIH grants AI155171, AI116228, AI078799, HL134539, DA047034, MH134823, amfAR ARCHE and the Bill and Melinda Gates Foundation.
Keywords: AIDS vaccine; AIDS/HIV; Virology.
Conflict of interest statement
Figures










Similar articles
-
Persistent elite controllers as the key model to identify permanent HIV remission.Curr Opin HIV AIDS. 2025 Mar 1;20(2):165-171. doi: 10.1097/COH.0000000000000907. Epub 2025 Jan 17. Curr Opin HIV AIDS. 2025. PMID: 39773856 Free PMC article. Review.
-
Distinct viral reservoirs in individuals with spontaneous control of HIV-1.Nature. 2020 Sep;585(7824):261-267. doi: 10.1038/s41586-020-2651-8. Epub 2020 Aug 26. Nature. 2020. PMID: 32848246 Free PMC article.
-
HIV Proviral Burden, Genetic Diversity, and Dynamics in Viremic Controllers Who Subsequently Initiated Suppressive Antiretroviral Therapy.mBio. 2021 Dec 21;12(6):e0249021. doi: 10.1128/mBio.02490-21. Epub 2021 Nov 16. mBio. 2021. PMID: 34781741 Free PMC article.
-
In-Depth Characterization of Full-Length Archived Viral Genomes after Nine Years of Posttreatment HIV Control.Microbiol Spectr. 2023 Feb 14;11(1):e0326722. doi: 10.1128/spectrum.03267-22. Epub 2023 Jan 24. Microbiol Spectr. 2023. PMID: 36692300 Free PMC article.
-
New Approaches to Multi-Parametric HIV-1 Genetics Using Multiple Displacement Amplification: Determining the What, How, and Where of the HIV-1 Reservoir.Viruses. 2021 Dec 10;13(12):2475. doi: 10.3390/v13122475. Viruses. 2021. PMID: 34960744 Free PMC article. Review.
Cited by
-
Time to HIV viral rebound and frequency of post-treatment control after analytical interruption of antiretroviral therapy: an individual data-based meta-analysis of 24 prospective studies.Nat Commun. 2025 Jan 21;16(1):906. doi: 10.1038/s41467-025-56116-1. Nat Commun. 2025. PMID: 39837813 Free PMC article.
-
Applications and limitations of the passenger hypothesis for HIV reservoir persistence and cure.J Virol. 2025 Jul 22;99(7):e0071425. doi: 10.1128/jvi.00714-25. Epub 2025 Jun 4. J Virol. 2025. PMID: 40464563 Free PMC article. Review.
-
HIV controllers: hope for a functional cure.Front Immunol. 2025 Feb 25;16:1540932. doi: 10.3389/fimmu.2025.1540932. eCollection 2025. Front Immunol. 2025. PMID: 40070826 Free PMC article. Review.
-
Persistent elite controllers as the key model to identify permanent HIV remission.Curr Opin HIV AIDS. 2025 Mar 1;20(2):165-171. doi: 10.1097/COH.0000000000000907. Epub 2025 Jan 17. Curr Opin HIV AIDS. 2025. PMID: 39773856 Free PMC article. Review.
-
HIV-1 control in vivo is related to the number but not the fraction of infected cells with viral unspliced RNA.Proc Natl Acad Sci U S A. 2024 Sep 3;121(36):e2405210121. doi: 10.1073/pnas.2405210121. Epub 2024 Aug 27. Proc Natl Acad Sci U S A. 2024. PMID: 39190360 Free PMC article.
References
MeSH terms
Substances
Grants and funding
- R01 AI078799/AI/NIAID NIH HHS/United States
- K24 AI155233/AI/NIAID NIH HHS/United States
- R01 HL134539/HL/NHLBI NIH HHS/United States
- UM1 AI164570/AI/NIAID NIH HHS/United States
- R61 DA047034/DA/NIDA NIH HHS/United States
- UM1 AI164562/AI/NIAID NIH HHS/United States
- U01 AI135940/AI/NIAID NIH HHS/United States
- R37 AI155171/AI/NIAID NIH HHS/United States
- R33 DA047034/DA/NIDA NIH HHS/United States
- R01 AI152979/AI/NIAID NIH HHS/United States
- R01 MH134823/MH/NIMH NIH HHS/United States
- R01 AI176579/AI/NIAID NIH HHS/United States
- R01 AI130005/AI/NIAID NIH HHS/United States
- U01 AI117841/AI/NIAID NIH HHS/United States
- R01 DK120387/DK/NIDDK NIH HHS/United States
- UM1 AI164560/AI/NIAID NIH HHS/United States
- R33 AI116228/AI/NIAID NIH HHS/United States
- R21 AI116228/AI/NIAID NIH HHS/United States
- UM1 AI164566/AI/NIAID NIH HHS/United States